- Home
- ELTK vs XGN Comparison
ELTK vs XGN Comparison
Compare ELTK & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTK
- XGN
- Stock Information
- Founded
- ELTK 1970
- XGN 2002
- Country
- ELTK Israel
- XGN United States
- Employees
- ELTK N/A
- XGN N/A
- Industry
- ELTK Electrical Products
- XGN Medical Specialities
- Sector
- ELTK Technology
- XGN Health Care
- Exchange
- ELTK Nasdaq
- XGN Nasdaq
- Market Cap
- ELTK 73.9M
- XGN 72.3M
- IPO Year
- ELTK 1997
- XGN 2019
- Fundamental
- Price
- ELTK $11.00
- XGN $5.02
- Analyst Decision
- ELTK
- XGN Buy
- Analyst Count
- ELTK 0
- XGN 1
- Target Price
- ELTK N/A
- XGN $7.00
- AVG Volume (30 Days)
- ELTK 25.5K
- XGN 162.5K
- Earning Date
- ELTK 11-19-2024
- XGN 11-12-2024
- Dividend Yield
- ELTK 2.05%
- XGN N/A
- EPS Growth
- ELTK N/A
- XGN N/A
- EPS
- ELTK 0.85
- XGN N/A
- Revenue
- ELTK $48,090,000.00
- XGN $55,751,000.00
- Revenue This Year
- ELTK $7.47
- XGN $6.74
- Revenue Next Year
- ELTK $9.96
- XGN $17.32
- P/E Ratio
- ELTK $12.61
- XGN N/A
- Revenue Growth
- ELTK 7.22
- XGN 8.00
- 52 Week Low
- ELTK $9.00
- XGN $1.30
- 52 Week High
- ELTK $22.80
- XGN $6.22
- Technical
- Relative Strength Index (RSI)
- ELTK 51.56
- XGN 56.40
- Support Level
- ELTK $10.37
- XGN $4.71
- Resistance Level
- ELTK $11.00
- XGN $5.41
- Average True Range (ATR)
- ELTK 0.58
- XGN 0.56
- MACD
- ELTK -0.02
- XGN -0.07
- Stochastic Oscillator
- ELTK 53.17
- XGN 39.70
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnects. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.